ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
5 hedge funds and large institutions have $441K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$186K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$79K |
| 3 |
Morgan Stanley
New York
|
$17K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$12K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$147K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $186K | +$71.3K | +7,791 | +62% |
|
|
2
Citadel Advisors
Miami,
Florida
| $147K | -$12.7K | -1,390 | -8% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $79K | +$60.9K | +6,667 | +336% |
|
|
4
Morgan Stanley
New York
| $17K | +$16.5K | +1,844 | +3,023% |
|
|
5
UBS Group
Zurich,
Switzerland
| $12K | -$18.2K | -2,043 | -60% |
|